Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
NovoPath
| Company | NovoPath |
|---|---|
| Name of laboratory information system | NovoPath 360 |
| Contact | Promise Okeke |
| City, State | Bridgewater, NJ |
| Phone | — |
| Website | |
| Company provides list of client sites to potential customers on request | yes (partial list of comparable sites but prospective clients must sign a nondisclosure agreement) |
| Updates covered by standard software maintenance fee | all updates |
| Schedule for providing standard software updates to clients | monthly |
| Clients must install updates in specified timespans to avoid maintenance fee increase | no |
| Fee for software modifications to comply with federal regulations and laws | no |
| Year company began selling LISs (any brand or model) | 1999 |
| Most recent LIS go-live at a client site (based on August 2025 survey deadline) | Aug-2025 |
| Last product release or update for featured LIS | 144 |
| No. of U.S. sales and installations of LIS between August 2024–July 2025 | 14 sales |
| Total No. of U.S. sites operating LIS (hospitals/independent labs/clinics or group practices/public health labs/other sites) | — |
| • Approx. percentage of high-vol.* U.S. site installs/Low-vol.** U.S. site installs | 15%/85% |
| Foreign locations where company actively markets LIS for clinical lab use | none |
| • Foreign locations where LIS has been installed for clinical lab use | — |
| Human languages (other than English) supported by LIS | — |
| Approximate No. of employees in entire company | 70+ |
| Central hardware or service type | software-as-a-service |
| Programming languages and development applications or environments | ASP .Net Core, C#, HTML, JavaScript, TSQL (Transact-SQL) |
| Operating system(s) | Azure Cloud, Windows, Macintosh OS, Web |
| Databases | SQL server, MonogoDB, Redis |
| System includes full transaction logging | yes |
| • Chemistry/Hematology/Print barcoded collection labels | available but not installed/available but not installed/ installed at client sites |
| • Microbiology/Public health microbiology | not available/not available |
| • Blood bank donor/Blood bank transfusion | not available/not available |
| • Surgical pathology/Cytology | installed at client sites/installed at client sites |
| • Molecular pathology/Cytogenetics/Flow cytometry | installed at client sites (all 3 features) |
| • EHR interface for admission/discharge/transfer (ADT) | installed at client sites |
| • EHR interface for order entry/EHR interface for results reporting | installed at client sites/installed at client sites |
| • EHR interface+GQ3:GQ15 for packaging results into PDF format | installed at client sites |
| • EHR interface for packaging results into CDA1 format/CDA2 format | installed at client sites/installed at client sites |
| • Ad hoc reporting/Rules-based system | installed at client sites/installed at client sites |
| • Management and statistical reporting/Client services or CRM module | installed at client sites/installed at client sites |
| • POL link or Web portal to physician offices/Patient Web portal | installed at client sites/not available |
| • Commercial reference lab functionality/Compliance checking | installed at client sites/installed at client sites |
| • Comprehensive billing and accounts receivable or RCM | • Comprehensive billing and accounts receivable or RCM |
| • Materials management and inventory/Test partition | installed at client sites/installed at client sites |
| • Remote faxing/Remote printing | installed at client sites/installed at client sites |
| • HIPAA-standard transaction formats | installed at client sites |
| • Web-based remote inquiry of reports/Web access for order entry | installed at client sites/installed at client sites |
| • Management and tracking of specimens within lab/Before arriving in lab | installed at client sites/in testing |
| • QA tools/Environmental health | installed at client sites/not available |
| • Interfaces for sending orders from primary lab to reference lab, handling results return, and status updates | installed at client sites |
| • Business analytics/Clinical analytics | installed at client sites/installed at client sites |
| • Ability to schedule patient for test collection/Patient-based test registration | not available/not available |
| • Ability to coordinate with nurses for collections that phlebotomists cannot perform | not available |
| • Interfaces with public health databases using ELR as part of Promoting Interoperability | installed at client sites |
| • Results for tests run using different methods show method on clinical reports | installed at client sites |
| Barcode symbologies supported by LIS | Code 39, Code 128, DataMatrix (LIS also supports QR codes) |
| Ability to use artificial intelligence (e.g., machine-learning software) with LIS | planned for future |
| • Microbiology (culture and sensitivity) | no |
| • Other reportable diseases or conditions (e.g., blood lead, immunology, etc.) | no |
| • Tumor diagnosis and case data to regional cancer registry*** | yes |
| LIS bidirectionally interfaces to other IT vendors’ lab systems in live sites | yes |
| LIS uses third-party middleware for LIS–instrument interfaces | no (interface directly) |
| Lab automation systems or workcells to which LIS has a direct interface | Beckman Coulter, Sysmex, Thermo Scientific, Roche Diagnostics |
| LIS supports use of SNOMED CT | yes, for all cases |
| LIS automatically ingests and applies electronic updates of tables and rules from organizations and government agencies | yes (CAP cancer checklist) |
| LIS allows for image capture, display, reporting | yes |
| LIS provides indexed field in each test definition for LOINC code | yes |
| Client gets copy of source code/User group that meets on established schedule | no/yes (via webinar) |
| Qualified users or third parties can modify or augment LIS functions or features | yes (client users) |
| Methods by which users can tailor LIS in their own setting | ad hoc query tools, user-defined interfaces, dictionary settings, workflow configuration, tailored worklists |
| Distinguishing product features (supplied by company) | library of dashboards to choose from that are prebuilt for clients; clients can also create their own dashboards; discrepancy module that automatically detects discrepancies within the platform; automatic case distribution, with parameters set by client, ensures equal workload among pathologists |
| Notes | †formerly NovoPath |